FSG
Venture capital · Lund, Sweden · Europe
FSG is a venture capital firm based in Lund, Sweden, that grew out of Fårö Capital, the family office Christer Fåhraeus founded in 2000. It invests in revenue-generating, commercial-stage companies at the intersection of life science and technology.
Invests inHealthcare & Biotech
In its own wordslife sciencedigital healthmedtechlife science toolsbiotechsustainability
Your fit with FSG
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFSG lists 24 checked portfolio companies on its own site and is named in 3 funding rounds, 3 of them as lead. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (58%), AI & Machine Learning (10%) and Enterprise Software (7%). 79% of its companies are based in Sweden. It invests most often alongside Industrifonden, Chalmers Ventures and Luminar Ventures.
Counts come from funding rounds that name FSG, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not FSG's whole history. Rounds on record name 2 companies; its own site lists 24. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 0% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 2 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 59th | 24 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 88th | 58% in its largest sector |
| Reach | 70th | 4 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 58% | 15% |
| AI & Machine Learning | 10% | 18% |
| Enterprise Software | 7% | 8% |
| E-commerce & Marketplaces | 7% | 6% |
| Cybersecurity | 7% | 4% |
| Food & Agriculture | 3% | 3% |
| Media & Entertainment | 3% | 4% |
| Industrial & Manufacturing | 3% | 7% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Industrifonden | 3 |
| Chalmers Ventures | 2 |
| Luminar Ventures | 2 |
| Almi | 1 |
| Brightly Ventures | 1 |
| Evli Growth Partners | 1 |
| Further Than Capital | 1 |
| GU Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers24100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare FSG head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with FSG| Date | Company | Stage |
|---|---|---|
| 17 Jun 2026 | Seed Led | |
| 18 Aug 2025 | Seed Led | |
| 3 Feb 2025 | Series B Led |
Round details for FSG
Amounts, full round histories and every co-investor in FSG's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
24 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Airsonett develops and provides a medical device for the treatment of allergic asthma and atopic dermatitis | Healthcare & Biotech | Portfolio page | ||
| Aplagon is a clinical stage biopharmaceutical company developing first-in-class therapeutics for thromboinflammatory diseases. | Healthcare & Biotech | Feb 2025Series B · 2 rounds | Page + round | |
| Aqilion is a biotech company that focuses on developing innovative new treatments for diseases caused by chronic inflammation and dysfunctional immune reactions | Healthcare & Biotech | Portfolio page | ||
| Atley Solutions develops and commercializes products and services for radiopharmaceuticals, particularly At-211 | Healthcare & Biotech | Portfolio page | ||
| Beamonics produces gas analysis products, including laser-based gas analyzers for various industries | Industrial & ManufacturingE-commerce & Marketplaces | Portfolio page | ||
| BrightBid provides AI ad optimization software and marketing agency services to help businesses manage and improve their online advertising campaigns. | AI & Machine LearningMedia & Entertainment | Portfolio page | ||
| Captario provides a platform for decision intelligence and portfolio management in the pharmaceutical industry. | Healthcare & Biotech | Portfolio page | ||
| Checkin.com provides identity verification services, including ID scanning, face recognition, and KYC tools, for secure user onboarding | FintechCybersecurity | Portfolio page | ||
| The company provides online psychological therapy and counseling services. | Healthcare & Biotech | Portfolio page | ||
| Evam provides incident response software for first responders | CybersecurityHealthcare & Biotech | Portfolio page | ||
| Fidabio develops and provides a platform for flow induced dispersion analysis for biophysics applications | Healthcare & Biotech | Portfolio page | ||
| Iconovo develops inhaled medicines in partnership with pharma companies, combining patented dry powder inhalers and formulation expertise for end-to-end development. | Healthcare & Biotech | Portfolio page | ||
| IntuiCell develops software based on genuine intelligence, inspired by instinctive learning in newborn creatures. | AI & Machine LearningEnterprise Software | Portfolio page | ||
| Melius Pharma develops treatments for severe diseases with high unmet clinical needs at a reduced development risk. | Healthcare & Biotech | Portfolio page | ||
| Nordhealth builds products that redefine healthcare and provides software and APIs to help improve care, save time and grow healthcare businesses. | Healthcare & Biotech | Portfolio page | ||
| Nygen provides an AI platform for single-cell discovery | Healthcare & Biotech | Portfolio page | ||
| Oncorena is developing a treatment for metastatic renal cancer based on orellanine, a naturally occurring substance from mushrooms. | Healthcare & Biotech | Portfolio page | ||
| OssDsign is a developer and global provider of next generation orthobiologics products. | Healthcare & Biotech | Portfolio page | ||
| Promimic develops and provides a surface modification technology for implants to enhance bone growth and integration. | Healthcare & Biotech | Portfolio page | ||
| SAGA Diagnostics develops and commercializes a blood-based test for early detection of molecular residual disease in cancer patients | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- fsg.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 3 Feb 2025
- Companies checked
- 24
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get FSG's profile as data
Pull FSG's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/fsg.vc
# also
GET /v1/firms/fsg.vc/portfolio
GET /v1/firms/fsg.vc/coinvestors
GET /v1/firms/fsg.vc/news